Stockscreener 앱 받기
17.70
1.61%
-0.29
시간 외 거래:
17.49
-0.21
-1.19%
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
Fulgent Genetics unveils FulGenome upgrade with higher repeat expansion detection - Traders Union
Trading Systems Reacting to (FLGT) Volatility - Stock Traders Daily
Fulgent Deadline Alert - TMX Newsfile
How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments - Yahoo Finance
Fulgent Genetics Inc. (FLGT) Q1 2026 Earnings: Wide EPS Miss Sends Shares LowerLong-Term Guidance - newsline.com
Fulgent Genetics CSO Gao Hanlin sells $30,190 in stock By Investing.com - Investing.com Australia
How Fulgent Genetics Inc. (FLGT) Affects Rotational Strategy Timing - Stock Traders Daily
Fulgent Genetics CSO Gao Hanlin sells $30,190 in stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) insider sale covers RSU taxes - Stock Titan
Fulgent Genetics (FLGT) CFO reports tax withholding of vested RSU shares - Stock Titan
Fulgent Genetics (FLGT) CSO sells 1,688 shares to cover RSU tax - Stock Titan
Fulgent (NASDAQ: FLGT) CEO RSU vest triggers 4,392-share tax withholding - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) Form 144 lists 45,304 vested shares; small prior sale - Stock Titan
Fulgent Presents Updated Phase 2 FID-007 + Cetuximab Data at ASCO Showing 61.9% ORR - TradingView
Fulgent Genetics (FLGT) Presents Promising Data on Head and Neck Cancer Treatment - GuruFocus
Strong FID-007 Phase 2 results for Fulgent Genetics (NASDAQ: FLGT) - Stock Titan
Fulgent Presents Updated FID-007 Data at ASCO 2026 - The Joplin Globe
Fulgent Genetics COO Jian Xie sells $21,137 in company stock By Investing.com - Investing.com Australia
Fulgent Genetics COO Jian Xie sells $21,137 in company stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) exec sells shares for tax withholding - Stock Titan
[Form 4] Fulgent Genetics, Inc. Insider Trading Activity - Stock Titan
Fulgent Genetics (FLGT) CSO sells 945 shares to cover tax obligations - Stock Titan
Ming Hsieh (FLGT) reports 32% Fulgent Genetics stake and major share pledges - Stock Titan
Fulgent Genetics (FLGT) CEO reports RSU tax withholding and large trust holdings - Stock Titan
Fulgent Genetics (FLGT) price target decreased by 28.85% to 18.87 - MSN
FLGT Stock Price and Chart — NASDAQ:FLGT - TradingView
(FLGT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Law firm investigates Fulgent Genetics for possible securities law violations after revenue miss. - Pluang
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire
Fulgent Genetics Presents Promising Phase 2 FID-007 & Cetuximab Data for Head and Neck Cancer at ASCO 2026 - Minichart
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting - BioSpace
Fulgent Announces Rapid Oral Full Abstract Publication for FID-00 - The National Law Review
Fulgent reports interim data for cancer drug FID-007 trial By Investing.com - Investing.com South Africa
Fulgent reports interim data for cancer drug FID-007 trial - Investing.com
Fulgent Announces ASCO Rapid Oral Abstract Showing 60% ORR, 7.2‑mo mPFS for FID-007 plus Cetuximab - TradingView
Fulgent (NASDAQ: FLGT) reports 60% ORR in Phase 2 FID-007 cancer trial - Stock Titan
Fulgent Genetics Highlights Promising FID-007 Phase 2 Results - TipRanks
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
Fulgent Genetics targets wider engagement at APG2026 San Diego exhibit fair - Traders Union
FLGT Stock Chart | FULGENT GENETICS INC (NASDAQ:FLGT) - ChartMill
Fulgent Genetics (FLGT) director receives stock units and 8,426-share option grant - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) director receives 11,117 RSUs - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) director awarded 11,117 restricted stock units - Stock Titan
Fulgent Genetics Shareholders Approve New 2026 Equity Plan - TipRanks
1.63%
2.88%
자본화:
|
볼륨(24시간):